Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial

Abstract Background Although clozapine is an effective option for treatment-resistant schizophrenia (TRS), there are still 1/3 to 1/2 of TRS patients who do not respond to clozapine. The main purpose of this randomized, double-blind, placebo-controlled trial was to explore the amisulpride augmentati...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Ming-Huan Zhu, Zhen-Jing Liu, Qiong-Yue Hu, Jia-Yu Yang, Ying Jin, Na Zhu, Ying Huang, Dian-Hong Shi, Min-Jia Liu, Hong-Yang Tan, Lei Zhao, Qin-Yu Lv, Zheng-Hui Yi, Feng-Chun Wu, Ze-Zhi Li
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	KeAi Communications Co., Ltd. 2022-10-01
Seri Bilgileri:	Military Medical Research
Konular:	Schizophrenia Clozapine-resistant treatment refractory schizophrenia Clozapine Amisulpride Augmentation
Online Erişim:	https://doi.org/10.1186/s40779-022-00420-0
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!